Longterm experience of magnerot administration in patients with mitral valve prolapse
Within 15 years observation 31 patients with prolaps the mitral valve, regularly accepting magnerot, in a dose of 1500 mg a day during all period of observation by 3-month's courses 2 times a year was spent. Features of dynamics of a clinical picture, their interrelation with phenotypic express...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
InterMedservice
2011-03-01
|
| Series: | Евразийский Кардиологический Журнал |
| Subjects: | |
| Online Access: | https://www.heartj.asia/jour/article/view/5423 |